Paul D. Rubin, Senior VP Clinical Development & CMO at XOMA Corp (XOMA), sold 17,649 shares at $6.31 ($111K) on 2014-03-18, disclosed to the SEC on 2014-03-20.
Scheduled sale ($111k) by Senior VP Clinical Development & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.31 | 6,000 | $38K | 34.0% |
| 2 | $6.32 | 4,661 | $29K | 26.4% |
| 3 | $6.32 | 6,988 | $44K | 39.6% |
| Total | $6.32 avg | 17,649 | $111K | 100% |
| Filing → |
| BIOA | SELL | 2026-02-03 | $139K | — | Filing → |
| BIOA | SELL | 2026-01-06 | $191K | — | Filing → |
| BIOA | SELL | 2025-12-11 | $216K | — | Filing → |